Education:

BA, Duke University 1998
MD, University of Louisville School of Medicine, 2002
Internal Medicine Residency, Beth Israel Deaconess Medical Center, Harvard Medical School 2005
Chief Medical Resident, Beth Israel Deaconess Medical Center, Harvard Medical School 2007
Hematology and Oncology Fellowship, Beth Israel Deaconess Medical Center, Harvard Medical School, 2009
Board Certified  ABIM, Internal Medicine, 2005
Board Certified  ABIM, Hematology, 2009
Board Certified ABIM  Oncology,  2009

Cirriculum Vitae

Current Positions:

Director, Breast Cancer Multidisciplinary Clinic, James Graham Brown Cancer Center
Assistant Professor of Medicine, Department of Medicine University of Louisville
Associate Division Director, Division of Oncology/Hematology

Clinical Focus and Research:

My clinical expertise is in the multidisciplinary treatment of all stages of breast cancer and survivorship.  I have a particular interest in neoadjuvant chemotherapy, and the unique challenges of treating of younger women with breast cancer.  I serve as director of the Breast Multidisciplinary Clinic, which remains the first and thus longest running site in Kentucky accredited by the National Accredited Program of Breast Centers (NAPBC.)  In this capacity, I work closely with mammographers, pathologists, breast surgeons and radiation oncologists to ensure patients get the most effective and accurate treatment specific for his or her tumor type.

My original research interests include understanding and eliminating cancer health care disparities and inequalities.  Recent projects most notably include a study aimed at improving adherence to oral anti estrogens in breast cancer patients utilizing novel packaging and the Mobile Mammography Utilization Project and Research Group of which she is a founder and co-director.  The latter project is a multidisciplinary research database of the Kentucky Cancer Program's mobile mammography van and is the largest reported in the literature.  Additionally, our team conducts several clinical trials on breast cancer including pharmaceutical, cooperative group and investigator initiated so that our patients have access to novel and potentially more targeted treatments.

Additionally I am a recent member of the ASCO American Society of Clinical Oncology Health Disparities Advisory Group which involves increasing education and awareness among the oncology community, quality assessment and improvement programs as well as policy and advocacy for health disparities on a regional and national level.

Literature Cited:

1. Efficacy of Concurrent Chemoradiotherapy for Patients With Locally Recurrent or Advanced Inoperable Breast Cancer.Shaughnessy JN, Meena RA, Dunlap NE, Jain D, Riley EC, Quillo AR, Dragun AE.Clin Breast Cancer. 2014 Oct 22. pii: S1526-8209(14)00227-4. doi: 10.1016/j.clbc.2014.10.007. [Epub ahead of print ]PMID:25454741.
2. Mobile Mammography, Race, and Insurance: Use Trends Over a Decade at a Comprehensive Urban Cancer Center.Mizuguchi S, Barkley L, Rai S, Pan J, Roland L, Crawford S, Riley EC. J Oncol Pract. 2014 Nov 4. pii: JOP.2014.001477. [Epub ahead of print] PMID:25371543.
3. A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfaction. Dragun AE, Quillo AR, Riley EC, Roberts TL, Hunter AM, Rai SN, Callender GG, Jain D, McMasters KM, Spanos WJ. Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):e123-8. doi: 10.1016/j.ijrobp.2012.10.021. Epub 2012 Nov 27.PMID:23195779.
4. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center. Dragun AE, Pan J, Riley EC, Kruse B, Wilson MR, Rai S, Jain D. Am J Clin Oncol. 2013 Aug;36(4):375-80. doi: 10.1097/COC.0b013e318248da47. PMID:22643566.
5. Delay of Adjuvant Chemotherapy After Elective Mastectomy and Immediate Reconstruction in Breast-conservation Candidates: A Matched-pair Analysis. Barry PN, Riley EC, Pan J, Crew JB, Lee K, Jain D, Kruse B, Quillo AR, Rai S, Dragun AE. Am J Clin Oncol. 2014 Dec;37(6):575-9. doi: 10.1097/COC.0b013e318280d79f. PMID:23466579.

PubMed Information